Authors: DIERLAMM J STEFANOVA M EGGERT J LEBERECHT P SEEGER D MICHAUX L WESTERHAUSEN B HOSSFELD DK

Citation: J. Dierlamm et al., NOVEL PHILADELPHIA VARIANT TRANSLOCATION T(Y-9-22) (Q12-Q34-Q11) IN ACASE OF CML, Annals of oncology, 9, 1998, pp. 392-392

Authors: DRECHSLER S BRUNTSCH U EGGERT J GROTEKIEHN J GOSSE H BANGERTER M UKENA D OEHM C MEZGER J FAERBER L IMHOFF W UNTCH M GALLMEIER WM

Citation: S. Drechsler et al., COMPARISON OF 3 TROPISETRON-CONTAINING ANTIEMETIC REGIMENS IN THE PROPHYLAXIS OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED EMESIS AND NAUSEA, Supportive care in cancer, 5(5), 1997, pp. 387-395

Authors: EISING EG GRIES P EGGERT J SCHEULEN ME

Citation: Eg. Eising et al., DOES THE MULTIDRUG-RESISTANCE MODULATOR CYCLOSPORINE-A INCREASE THE CARDIOTOXICITY OF HIGH-DOSE ANTHRACYCLINE CHEMOTHERAPY, Acta oncologica, 36(7), 1997, pp. 735-740

Authors: DRECHSLER S EGGERT J GOSSE H UKENA D GROTEKIEHN J OEHM C FAERBER L BRUNTSCH U

Citation: S. Drechsler et al., TROPISETRON MONOTHERAPY VS 2 TROPISETRON COMBINATIONS IN CHEMOTHERAPY-INDUCED EMESIS, European journal of cancer, 31A, 1995, pp. 1233-1233

Authors: GAO L XUE YY CHEN F XIONG Q MENG RL RAMERIZ D CHU CW EGGERT J MAO HK

Citation: L. Gao et al., UNIVERSAL ENHANCEMENT OF T-C UNDER HIGH-PRESSURE IN HGBA2CAM-1CUMO2M+2+DELTA, Physica. C, Superconductivity, 235, 1994, pp. 1493-1494

Authors: BRUNTSCH U DRECHSLER S EGGERT J GOSSE H UKENA D IMHOFF W FAERBER L

Citation: U. Bruntsch et al., PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING BY TROPISETRON(NAVOBAN) ALONE OR IN COMBINATION WITH OTHER ANTIEMETIC AGENTS, Seminars in oncology, 21(5), 1994, pp. 7-11